These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

62 related articles for article (PubMed ID: 1112981)

  • 1. Human C3 and C5: subunit structure and modifications by trypsin and C42-C423.
    Nilsson UR; Mandle RJ; McConnell-Mapes JA
    J Immunol; 1975 Feb; 114(2 pt 2):815-22. PubMed ID: 1112981
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cleavage of human C5 by trypsin: characterization of the digestion products by gel electrophoresis.
    Minta JO; Man DP
    J Immunol; 1977 Nov; 119(5):1597-1602. PubMed ID: 410877
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fifth component of guinea pig complement: purification and characterization.
    Kinoshita T; Hong K; Kondo K; Inoue K
    J Immunol; 1981 Jun; 126(6):2414-8. PubMed ID: 7229382
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Generation of biologic activity from the purified alpha-chain of C5.
    Phan SH; Ward PA
    J Immunol; 1979 Dec; 123(6):2735-40. PubMed ID: 501087
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Proteolysis of the C5b-7 complex: cleavage of the C5b and C6 subunits and its effect on the interaction of the complex with phospholipid bilayers.
    Yamamoto KI
    J Immunol; 1980 Oct; 125(4):1745-50. PubMed ID: 6997387
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Activation of the fifth and sixth components of the human complement system: C6-dependent cleavage of C5 in acid and the formation of a bimolecular lytic complex, C5b,6a.
    Hammer CH; Hänsch G; Gresham HD; Shin ML
    J Immunol; 1983 Aug; 131(2):892-8. PubMed ID: 6863934
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Structural features and biologic properties of fragments obtained by limited proteolysis of C3.
    Conroy MC; Ozols J; Lepow IH
    J Immunol; 1976 Jun; 116(6):1682-7. PubMed ID: 774990
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Generation of C3a anaphylatoxin from human C3 by human mast cell tryptase.
    Schwartz LB; Kawahara MS; Hugli TE; Vik D; Fearon DT; Austen KF
    J Immunol; 1983 Apr; 130(4):1891-5. PubMed ID: 6339618
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expression of C5a-like biological activities by the fifth component of human complement (C5) upon limited digestion with noncomplement enzymes without release of polypeptide fragments.
    Wetsel RA; Kolb WP
    J Exp Med; 1983 Jun; 157(6):2029-48. PubMed ID: 6222137
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evidence for the presence of two pyridine nucleotide-binding sites on the beta subunit of the Escherichia coli pyridine nucleotide transhydrogenase.
    Glavas NA; Bragg PD
    Biochem Mol Biol Int; 1995 Feb; 35(2):297-306. PubMed ID: 7663384
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Studies on the mechanism of bacterial resistance to complement-mediated killing. VI. IgG increases the bactericidal efficiency of C5b-9 for E. coli 0111B4 by acting at a step before C5 cleavage.
    Joiner KA; Goldman RC; Hammer CH; Leive L; Frank MM
    J Immunol; 1983 Nov; 131(5):2570-5. PubMed ID: 6355297
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The membrane attack complex of complement: relation of C7 to the metastable membrane binding site of the intermediate complex C5b-7.
    Preissner KT; Podack ER; Müller-Eberhard HJ
    J Immunol; 1985 Jul; 135(1):445-51. PubMed ID: 3998468
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Active sites in complement components C5 and C3 identified by proximity to indels in the C3/4/5 protein family.
    Low PJ; Ai R; Ogata RT
    J Immunol; 1999 Jun; 162(11):6580-8. PubMed ID: 10352274
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Beta-endorphin-related peptides in the human pituitary. Isolation and characterization of major immunoreactive peptides, including the formerly unrecognized peptide beta-endorphin 1-18.
    Vuolteenaho O
    Acta Physiol Scand Suppl; 1984; 531():1-84. PubMed ID: 6091413
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The activation of C5 in the fluid phase and in the absence of C3 through the classical pathway of the complement system.
    Kitamura H; Tsuboi M; Nagaki K
    Immunology; 1986 Jul; 58(3):459-65. PubMed ID: 3733147
    [TBL] [Abstract][Full Text] [Related]  

  • 16. New subunit in L-phenylalanine oxidase from Pseudomonas sp. P-501 and the primary structure.
    Mukouyama EB; Suzuki H; Koyama H
    Arch Biochem Biophys; 1994 Feb; 308(2):400-6. PubMed ID: 8109968
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comprehensive mass spectrometric analysis of the 20S proteasome complex.
    Huang L; Burlingame AL
    Methods Enzymol; 2005; 405():187-236. PubMed ID: 16413316
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Trypsin-activated complex of human factor B with cobra venom factor (CVF), cleaving C3 and C5 and generating a lytic factor for unsensitized guinea pig erythrocytes. II. Physico-chemical characterization of the activated complex.
    Miyama A; Kato T; Yokoo J; Kashiba S
    Biken J; 1975 Dec; 18(4):205-14. PubMed ID: 1218075
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The opsonic fragment of the third component of human complement (C3).
    Stossel TP; Field RJ; Gitlin JD; Alper CA; Rosen FS
    J Exp Med; 1975 Jun; 141(6):1329-47. PubMed ID: 236357
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Subunit composition and structure of subcomponent C1q of the first component of human complement.
    Reid KB; Porter RR
    Biochem J; 1976 Apr; 155(1):19-23. PubMed ID: 938474
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.